Assistance programs available for medications commonly used in transplant patients
Pharmaceutical manufacturers have programs available to supply medications to indigent patients at little or no cost. Enrolling needy patients into these programs should increase patient compliance to medications, minimize patient and institution financial burdens, and decrease adverse events associ...
Gespeichert in:
| Veröffentlicht in: | Clinical transplantation 2000-08, Vol.14 (4), p.269-281 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 281 |
|---|---|
| container_issue | 4 |
| container_start_page | 269 |
| container_title | Clinical transplantation |
| container_volume | 14 |
| creator | Chisholm, Marie A Tackett, Kimberly L Kendrick, Bridgett D DiPiro, Joseph T |
| description | Pharmaceutical manufacturers have programs available to supply medications to indigent patients at little or no cost. Enrolling needy patients into these programs should increase patient compliance to medications, minimize patient and institution financial burdens, and decrease adverse events associated with medication noncompliance. However, access to assistance programs by patients in need is limited if physicians and other health care providers are unaware of the existence of such programs or not informed of each program's enrollment process. The literature is void of a manuscript describing assistance programs available for commonly prescribed medications used in transplant patients. This article offers a concise summary of medication assistance programs available through the pharmaceutical industry to assist in the procurement of medications that are commonly prescribed for the transplant population, including immunosuppressants, antibacterials, gastrointestinal, cardiovascular, and hypoglycemic agents. This article should be used by health care professionals as a guide to the availability and requirements of medication assistance programs. |
| doi_str_mv | 10.1034/j.1399-0012.2000.140401.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71747133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71747133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4371-f31b260c4ddbc5ef58a7824d7a227e002afc99a46bc928a1a51a660e8370bdf3</originalsourceid><addsrcrecordid>eNqNkU1vEzEQhq2Kqg2Fv4CMhLht6q-11zfaiBakCqQqUo_WrNeLHPYjeDaQ_Ps62qhw5OTR-JnXo8eEvOdsyZlU15sll9YWjHGxFIzlrmKK8eX-jCxebl6RBbNM5FrLS_IacZO7muvyglxyZlXJrV6QxxvEiBMMPtBtGn8k6JHCb4gd1F2g7ZhoH5roYYrjgNSPfT8O3YHuMDQ0DnRKMOC2g2Gi28yEYcI35LyFDsPb03lF1nef16svxcP3-6-rm4fCK2l40UpeC828apral6EtKzCVUI0BIUxgTEDrrQWla29FBRxKDlqzUEnD6qaVV-TjHJvX_rULOLk-og9d3iWMO3SGG2W4lBm0M-jTiJhC67Yp9pAOjjN39Ok27mjNHa25o083-3T7PPvu9Miuzh7-mZwFZuDDCQD00LVZh4_4l1OiErbK2KcZ-xO7cPj_Bdxq_TjXOaKYI_J3hf1LBKSfThtpSvf07d5JfWv5Wj85LZ8BndyhHQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71747133</pqid></control><display><type>article</type><title>Assistance programs available for medications commonly used in transplant patients</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Chisholm, Marie A ; Tackett, Kimberly L ; Kendrick, Bridgett D ; DiPiro, Joseph T</creator><creatorcontrib>Chisholm, Marie A ; Tackett, Kimberly L ; Kendrick, Bridgett D ; DiPiro, Joseph T</creatorcontrib><description>Pharmaceutical manufacturers have programs available to supply medications to indigent patients at little or no cost. Enrolling needy patients into these programs should increase patient compliance to medications, minimize patient and institution financial burdens, and decrease adverse events associated with medication noncompliance. However, access to assistance programs by patients in need is limited if physicians and other health care providers are unaware of the existence of such programs or not informed of each program's enrollment process. The literature is void of a manuscript describing assistance programs available for commonly prescribed medications used in transplant patients. This article offers a concise summary of medication assistance programs available through the pharmaceutical industry to assist in the procurement of medications that are commonly prescribed for the transplant population, including immunosuppressants, antibacterials, gastrointestinal, cardiovascular, and hypoglycemic agents. This article should be used by health care professionals as a guide to the availability and requirements of medication assistance programs.</description><identifier>ISSN: 0902-0063</identifier><identifier>EISSN: 1399-0012</identifier><identifier>DOI: 10.1034/j.1399-0012.2000.140401.x</identifier><identifier>PMID: 10945196</identifier><language>eng</language><publisher>Copenhagen: Munksgaard International Publishers</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antihypertensive Agents - therapeutic use ; Biological and medical sciences ; Gastrointestinal Agents - therapeutic use ; Humans ; Hypoglycemic Agents - therapeutic use ; Hypolipidemic Agents - therapeutic use ; Immunosuppressive Agents - therapeutic use ; Medical Assistance ; Medical sciences ; medication assistance programs ; Organ Transplantation ; pharmaceutical companies ; Pharmaceutical Services ; Postoperative Complications - prevention & control ; Program Development ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; transplant patients ; United States</subject><ispartof>Clinical transplantation, 2000-08, Vol.14 (4), p.269-281</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4371-f31b260c4ddbc5ef58a7824d7a227e002afc99a46bc928a1a51a660e8370bdf3</citedby><cites>FETCH-LOGICAL-c4371-f31b260c4ddbc5ef58a7824d7a227e002afc99a46bc928a1a51a660e8370bdf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1034%2Fj.1399-0012.2000.140401.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1034%2Fj.1399-0012.2000.140401.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1428298$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10945196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chisholm, Marie A</creatorcontrib><creatorcontrib>Tackett, Kimberly L</creatorcontrib><creatorcontrib>Kendrick, Bridgett D</creatorcontrib><creatorcontrib>DiPiro, Joseph T</creatorcontrib><title>Assistance programs available for medications commonly used in transplant patients</title><title>Clinical transplantation</title><addtitle>Clin Transplantation</addtitle><description>Pharmaceutical manufacturers have programs available to supply medications to indigent patients at little or no cost. Enrolling needy patients into these programs should increase patient compliance to medications, minimize patient and institution financial burdens, and decrease adverse events associated with medication noncompliance. However, access to assistance programs by patients in need is limited if physicians and other health care providers are unaware of the existence of such programs or not informed of each program's enrollment process. The literature is void of a manuscript describing assistance programs available for commonly prescribed medications used in transplant patients. This article offers a concise summary of medication assistance programs available through the pharmaceutical industry to assist in the procurement of medications that are commonly prescribed for the transplant population, including immunosuppressants, antibacterials, gastrointestinal, cardiovascular, and hypoglycemic agents. This article should be used by health care professionals as a guide to the availability and requirements of medication assistance programs.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Medical Assistance</subject><subject>Medical sciences</subject><subject>medication assistance programs</subject><subject>Organ Transplantation</subject><subject>pharmaceutical companies</subject><subject>Pharmaceutical Services</subject><subject>Postoperative Complications - prevention & control</subject><subject>Program Development</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>transplant patients</subject><subject>United States</subject><issn>0902-0063</issn><issn>1399-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1vEzEQhq2Kqg2Fv4CMhLht6q-11zfaiBakCqQqUo_WrNeLHPYjeDaQ_Ps62qhw5OTR-JnXo8eEvOdsyZlU15sll9YWjHGxFIzlrmKK8eX-jCxebl6RBbNM5FrLS_IacZO7muvyglxyZlXJrV6QxxvEiBMMPtBtGn8k6JHCb4gd1F2g7ZhoH5roYYrjgNSPfT8O3YHuMDQ0DnRKMOC2g2Gi28yEYcI35LyFDsPb03lF1nef16svxcP3-6-rm4fCK2l40UpeC828apral6EtKzCVUI0BIUxgTEDrrQWla29FBRxKDlqzUEnD6qaVV-TjHJvX_rULOLk-og9d3iWMO3SGG2W4lBm0M-jTiJhC67Yp9pAOjjN39Ok27mjNHa25o083-3T7PPvu9Miuzh7-mZwFZuDDCQD00LVZh4_4l1OiErbK2KcZ-xO7cPj_Bdxq_TjXOaKYI_J3hf1LBKSfThtpSvf07d5JfWv5Wj85LZ8BndyhHQ</recordid><startdate>200008</startdate><enddate>200008</enddate><creator>Chisholm, Marie A</creator><creator>Tackett, Kimberly L</creator><creator>Kendrick, Bridgett D</creator><creator>DiPiro, Joseph T</creator><general>Munksgaard International Publishers</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200008</creationdate><title>Assistance programs available for medications commonly used in transplant patients</title><author>Chisholm, Marie A ; Tackett, Kimberly L ; Kendrick, Bridgett D ; DiPiro, Joseph T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4371-f31b260c4ddbc5ef58a7824d7a227e002afc99a46bc928a1a51a660e8370bdf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Medical Assistance</topic><topic>Medical sciences</topic><topic>medication assistance programs</topic><topic>Organ Transplantation</topic><topic>pharmaceutical companies</topic><topic>Pharmaceutical Services</topic><topic>Postoperative Complications - prevention & control</topic><topic>Program Development</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>transplant patients</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chisholm, Marie A</creatorcontrib><creatorcontrib>Tackett, Kimberly L</creatorcontrib><creatorcontrib>Kendrick, Bridgett D</creatorcontrib><creatorcontrib>DiPiro, Joseph T</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chisholm, Marie A</au><au>Tackett, Kimberly L</au><au>Kendrick, Bridgett D</au><au>DiPiro, Joseph T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assistance programs available for medications commonly used in transplant patients</atitle><jtitle>Clinical transplantation</jtitle><addtitle>Clin Transplantation</addtitle><date>2000-08</date><risdate>2000</risdate><volume>14</volume><issue>4</issue><spage>269</spage><epage>281</epage><pages>269-281</pages><issn>0902-0063</issn><eissn>1399-0012</eissn><abstract>Pharmaceutical manufacturers have programs available to supply medications to indigent patients at little or no cost. Enrolling needy patients into these programs should increase patient compliance to medications, minimize patient and institution financial burdens, and decrease adverse events associated with medication noncompliance. However, access to assistance programs by patients in need is limited if physicians and other health care providers are unaware of the existence of such programs or not informed of each program's enrollment process. The literature is void of a manuscript describing assistance programs available for commonly prescribed medications used in transplant patients. This article offers a concise summary of medication assistance programs available through the pharmaceutical industry to assist in the procurement of medications that are commonly prescribed for the transplant population, including immunosuppressants, antibacterials, gastrointestinal, cardiovascular, and hypoglycemic agents. This article should be used by health care professionals as a guide to the availability and requirements of medication assistance programs.</abstract><cop>Copenhagen</cop><pub>Munksgaard International Publishers</pub><pmid>10945196</pmid><doi>10.1034/j.1399-0012.2000.140401.x</doi><tpages>13</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0902-0063 |
| ispartof | Clinical transplantation, 2000-08, Vol.14 (4), p.269-281 |
| issn | 0902-0063 1399-0012 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71747133 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Anti-Bacterial Agents - therapeutic use Antihypertensive Agents - therapeutic use Biological and medical sciences Gastrointestinal Agents - therapeutic use Humans Hypoglycemic Agents - therapeutic use Hypolipidemic Agents - therapeutic use Immunosuppressive Agents - therapeutic use Medical Assistance Medical sciences medication assistance programs Organ Transplantation pharmaceutical companies Pharmaceutical Services Postoperative Complications - prevention & control Program Development Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart transplant patients United States |
| title | Assistance programs available for medications commonly used in transplant patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T20%3A26%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assistance%20programs%20available%20for%20medications%20commonly%20used%20in%20transplant%20patients&rft.jtitle=Clinical%20transplantation&rft.au=Chisholm,%20Marie%20A&rft.date=2000-08&rft.volume=14&rft.issue=4&rft.spage=269&rft.epage=281&rft.pages=269-281&rft.issn=0902-0063&rft.eissn=1399-0012&rft_id=info:doi/10.1034/j.1399-0012.2000.140401.x&rft_dat=%3Cproquest_cross%3E71747133%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71747133&rft_id=info:pmid/10945196&rfr_iscdi=true |